Αποτελέσματα Αναζήτησης
3 Οκτ 2019 · Given the high risk of acute kidney injury and its complication in case of a stone in single kidney as well as the significant incidence rate of stones in donors (3% symptomatic and 11% detected on imaging 42) the evaluation of past symptomatic or asymptomatic stones in LKD candidates is essential. Both imaging (computerized tomography) and ...
7 Οκτ 2022 · Historically, to minimize risks, living kidney donors have been highly selected and healthy. Operative risks are well-defined, yet concern remains about long-term risks. In the general population, even a mild reduction in glomerular filtration rate (GFR) is associated with cardiovascular disease, chronic kidney disease, and end-stage kidney ...
Since the first living-donor kidney transplantation in 1954, more than half a million living kidney donations have occurred and research has advanced knowledge about long-term donor outcomes. Donors in developed countries have a similar life expectancy and quality of life as healthy non-donors.
Kidney transplantation from a living donor, when available, is the treatment of choice for most patients with end stage renal disease, offering optimum patient and graft survival and reduced time on the national transplant waiting list.
There has been no reported stone recurrence in any of the donors to date and no stone on ultrasonography of eight donors with >1-year follow-up (mean 26 months, range 12-49 months). Conclusions: Asymptomatic renal stones are present in 5% of our donors.
Living donor kidney transplant is the recommended treatment for patients with kidney failure because of its association with better graft and recipient.
21 Μαΐ 2020 · living kidney donation. quality indicators. quality measurement. One-year patient and allograft survival have improved dramatically since the first successful kidney transplant in 1954. At many programs, 1-year allograft survival now exceeds 95%.
